Copyright
©The Author(s) 2019.
World J Clin Oncol. Jul 24, 2019; 10(7): 247-255
Published online Jul 24, 2019. doi: 10.5306/wjco.v10.i7.247
Published online Jul 24, 2019. doi: 10.5306/wjco.v10.i7.247
Figure 3 Tumor biopsy before and after treatment with nivolumab.
A: Pretreatment tumor biopsy in 2012, HE-stain. Note the intratumoral lymphocytes (TILS); B: Posttreatment tumor biopsy of the high-grade serous carcinoma of the left colic flexure in 2016, HE-stain. Note reduced intratumoral lymphocytes.
- Citation: Passler M, Taube ET, Sehouli J, Pietzner K. Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report. World J Clin Oncol 2019; 10(7): 247-255
- URL: https://www.wjgnet.com/2218-4333/full/v10/i7/247.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i7.247